Strengthens LGC’s position across the spectrum of clinical quality control tools market
Co-Diagnostics agrees to license CoPrimers™ for use in agricultural applications
Biosearch Technologies represents genomic tools for mission critical customer applications
Investment follows other acquisitions in oligonucleotide reagent and synthesised oligonucleotides markets
Replaces Dr Derek Craston, who completed two terms of five years each in this Office
Announcement a further strengthening of nucleic acid chemistry (NAC)
LGC operates out of 22 countries, with laboratories and centres across Europe and the US, as well as sites in Brazil, China and India.